Our team

• Team
• Scientific Advisory Board
• Board and observers
• Key investors
• Partners

• David Roblin

  Chief Executive Officer

  

• Lindsay Edwards

  Chief Technology Officer

  

• Rosie Rodriguez

  President, Growth

  

• Benjamin Swerner

  Chief Operating Officer

  

• Jake Taylor-King

  Chief Innovation Officer

  

• Dave Powell

  President of Drug Discovery

  

• Matthew Page

  VP, Data Science

  

• Michael Bronstein

  DeepMind Professor of AI, University of Oxford

• Caroline Uhler

  Professor, MIT and Co-director of The Eric & Wendy Schmidt Center, The Broad Institute

• Alex Shalek

  J. W. Kieckhefer Professor, Department of Chemistry, MIT

• Jacob Corn

  Professor of Genome Biology, ETH Zurich and Co-founder, Spotlight Therapeutics

• John Whittaker

  Director, MRC Biostatistics Unit and Professor of Biostatistics, University of Cambridge

• Marc Wein

  Associate Professor of Medicine, Mass. Gen. Hospital and Harvard Medical School

• Christine Aylward

  Managing Partner, Magnetic Ventures

• David Roblin

  Chief Executive Officer, Relation

• Charles Roberts

  Chair, Relation

• Jason Pontin

  General Partner, DCVC

• Zachary Bogue

  Managing Partner, DCVC

• Alex Morgan

  Partner, Khosla Ventures

• Jim Mellon

  Deputy-chair, Juvenescece

• Jake Taylor-King

  Chief Innovation Officer, Relation

• Benjamin Swerner

  Chief Operating Officer, Relation

• John Wesley

  Investment Director at NVentures

• Joanna Soroka

  Principal at Hitachi Ventures

• Magnetic Ventures

• DCVC

• Khosla Ventures

• Firstminute Capital

• NVIDIA - Investor

• GSK

  

• Novartis

• Hitachi Investments

• Ark Invest

• Deerfield

  

• GSK

  

• Novartis